1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Deluxe completed its acquisition of Celero Commerce on July 31, 2026, for an approximate $625 million cash purchase price plus certain seller transaction expenses, subject to adjustments. The closing was funded by borrowings under a new $800 million term loan and a $400 million revolving credit facility, with JPMorgan Chase Bank, N.A. as administrative agent. The company expects the deal to be accretive to adjusted EPS in the first full year after closing and will provide updated 2026 guidance with its second quarter results on August 5, 2026.
Cash purchase price of approximately $625 million, plus certain seller transaction expenses and other adjustments
New senior secured credit facilities: $400.0 million revolving facility and $800.0 million term loan, maturing July 31, 2031 for the revolver
Expected more than $15 million in cost synergies; deal expected to be accretive to adjusted EPS in the first full year after closing
Updated full-year 2026 guidance to be given with second quarter results on August 5, 2026
Cannae Holdings sold all of its interest in The Watkins Company, a flavoring maker, to KDSA Investment Partners on July 30, 2026, for $90 million in cash. Cannae says the sale monetizes a non-core asset and gives it capital for new investments or returns to shareholders.
Sale closed July 30, 2026, for cash proceeds of $90 million; the press release was issued July 31, 2026.
Cannae invested $80 million in Watkins in October 2024.
Cannae says the transaction represents a multiple on invested capital of approximately 1.2x and an IRR of nearly 10%, including sale proceeds, preferred dividends and fees received.
Chairman Douglas K. Ammerman said the proceeds could fund future investments or capital returns to shareholders.
Digital Asset Acquisition Corp. (DAAQ) said its extraordinary general meeting to approve its proposed business combination with Old Glory Holding Company (Old Glory Bank) will move from July 31, 2026 to 10:00 a.m. Eastern Time on August 14, 2026. The proposed resolutions are unchanged, and the July 29, 2026 deadline for redeeming Class A ordinary shares has already passed, so shareholders' vote on the deal is delayed by two weeks.
Meeting moved from July 31, 2026 to 10:00 a.m. ET on August 14, 2026, in New York and virtually.
Shareholders will vote on the proposed business combination with Old Glory Holding Company (Old Glory Bank), a Delaware corporation.
Share redemption deadline was July 29, 2026; the record date remains July 7, 2026.
The Form S-4 registration statement was declared effective by the SEC on July 6, 2026.
Soulpower Acquisition Corp. and SWB Holdings said the Virgin Islands Commercial Division court granted, on July 23, 2026, permission for the joint liquidators of Bank of Asia (BVI) Limited to sell certain assets to SWB LLC. The approval satisfies one of the conditions of the November 6, 2025 Asset Sale Agreement, but the filing says other conditions remain outstanding and SWB still needs a banking licence and deposit protection approval before it can engage in banking activities.
On July 23, 2026, the High Court granted the joint liquidators permission to sell certain Bank of Asia (BVI) Limited assets to SWB LLC or its affiliate, successor or designee.
Other Asset Sale Agreement conditions remain outstanding; SWB has submitted a banking licence application to the British Virgin Islands Financial Services Commission, which is under review.
The proposed business combination remains subject to closing conditions, including approval by Soulpower shareholders, and Pubco intends to file a Form S-4 registration statement.
Etsy completed its sale of Depop to eBay on July 30, 2026, receiving approximately $1.4 billion in cash, which includes a $1.2 billion purchase price plus $200 million of net adjustments and interest. Etsy plans to use the proceeds for general corporate purposes, including the accelerated share repurchase program outlined in its April 29 Shareholder Letter. The net proceeds remain subject to post-closing adjustments, and the actual gain on sale may differ materially from the $805.0 million pro forma estimate.
Closing date: July 30, 2026. Aggregate cash consideration is about $1.4 billion: $1.2 billion purchase price plus $200 million of net purchase price adjustments and interest.
Net cash proceeds remain subject to post-closing adjustments under the Purchase Agreement.
Pro forma balance sheet as of March 31, 2026 shows a gain on sale of $805.0 million; Etsy says the actual gain will be based on Depop's carrying value at closing and may differ materially.
Etsy plans to use proceeds for general corporate purposes, including accelerating its share repurchase program. A Second Amendment to the credit agreement with JPMorgan Chase Bank, N.A. dated July 30, 2026 is filed as Exhibit 10.1.
AiRWA Inc. completed its acquisition of Hong Kong Best Life Trade Co., Limited on July 30, 2026, paying the seller $30 million in USDT for 100% of the shares of Best Life's holding company, which gives AiRWA a 97% equity interest. The remaining $20 million of the base purchase price is due within 90 days of closing, and the consideration includes contingent earn-out payments tied to previously disclosed revenue milestones. The filing does not disclose Best Life's financial results, so shareholders cannot yet judge the deal's effect on earnings.
Closed July 30, 2026, after being announced July 27, 2026
$30 million paid in USDT; remaining $20 million payable within 90 days of closing
AiRWA holds a 97% equity interest in Best Life; earn-outs depend on revenue milestones
Pro forma and acquired-business financial statements to be filed by amendment within 71 calendar days
MarketAxess agreed to be acquired by Intercontinental Exchange (ICE) and released second-quarter 2026 results alongside the deal, with revenue flat year over year at $218.4 million. The company also withdrew its 2026 annual guidance and medium-term financial targets, canceled its earnings call, and suspended its monthly volume releases, so shareholders have no forward outlook from management while the deal is pending.
Q2 2026 total revenues were $218.4 million, flat versus $219.5 million in Q2 2025; net income was $68.3 million versus $71.2 million.
Diluted EPS was $1.93 versus $1.91 a year earlier; excluding notable items, EPS was $1.95 versus $2.00.
The company withdrew its 2026 annual guidance and medium-term financial targets and canceled the earnings call planned for August 7, 2026.
The board declared a $0.78 per share quarterly dividend, payable September 2, 2026 to holders of record on August 19, 2026.
MarketAxess signed a merger agreement on July 29, 2026, under which Intercontinental Exchange will acquire it for $167.00 per share in cash and it will become a wholly owned subsidiary of ICE. The price is a 33% premium to the July 29, 2026 closing price, and the Board unanimously recommended that stockholders approve the deal, which requires a majority of outstanding shares.
Cash consideration of $167.00 per share, a 33% premium to the July 29, 2026 closing price
Press release cites an equity value of about $6.0 billion and an enterprise value of about $5.7 billion
Closing expected in the first half of 2027, subject to stockholder approval, regulatory clearances and customary conditions
Agreement includes no-shop limits on seeking other offers and requires regular quarterly dividends to continue
On July 29, 2026, Intercontinental Exchange agreed to acquire MarketAxess Holdings for $167 per share in cash, a 33% premium to MarketAxess's July 29 closing price, for an equity value of about $6.0 billion and an enterprise value of about $5.7 billion. ICE plans to fund the deal with newly issued debt and cash, with a bridge facility of up to $6.25 billion as backup, and the company also raised its baseline quarterly share repurchases. The deal is expected to close in the first half of 2027, subject to MarketAxess stockholder approval and regulatory clearances.
$167 per share in cash, a 33% premium to the July 29, 2026 closing price; equity value about $6.0 billion, enterprise value about $5.7 billion
Financing: 100% cash consideration via newly issued debt; Bank of America bridge facility of up to $6.25 billion as backup
ICE raises baseline share repurchases to $400 million per quarter from $350 million; gross leverage of 3.4x at start, targeted at 3.0x or below within 18 to 24 months after close
$100 million in annual run-rate expense synergies expected within three years of close; expected to close in the first half of 2027
Group 1 Automotive reported second-quarter 2026 diluted earnings per share from continuing operations of $8.62, down from $10.77 a year earlier, on total revenues of $5.4 billion versus $5.7 billion. The company also agreed to acquire Hennessy Automobile Companies' 10 Atlanta-area dealerships for an expected purchase price of approximately $1.3 billion, funded in part by $1.25 billion of new debt, which will weigh on shareholders through added leverage and integration risk.
Q2 2026 net income from continuing operations was $103.0 million, versus $139.8 million a year earlier; revenues fell 5.6%
Hennessy deal: approximately $1.3 billion purchase price, $10.0 million escrow deposit within five business days, expected closing by the 160th day after signing
Financing: JPMorgan Chase committed a 364-day senior unsecured bridge facility of $1.25 billion
The company did not repurchase shares in Q2 2026; $306.3 million remained under its buyback authorization as of June 30, 2026
SEACOR Marine reported second quarter 2026 revenue of $54.6 million, down 10.2% from a year earlier, and net income of $3.3 million, compared with a net loss of $6.7 million in the second quarter of 2025. Net income was helped by $31.3 million of net gains on asset dispositions and impairments, and the company also announced that its Board is reviewing strategic alternatives, which may include a sale of the company, with no timetable set.
Q2 2026 revenue was $54.6 million, down from $60.8 million in Q2 2025 and up from $44.3 million in Q1 2026.
Operating income was $16.0 million, including $31.3 million of net gains on asset dispositions and impairments.
Net income was $3.3 million, or $0.12 per diluted share, versus a net loss of $6.7 million a year earlier.
The Board has retained independent financial advisors to review strategic alternatives, which may include a sale of the company; there is no assurance of a transaction and no timetable has been set.
Pioneer Bancorp, Inc. said on July 29, 2026, that it acquired The College Advisor of New York, a firm that provides college search and admissions guidance, and launched a College Advising Division. The filing does not state a purchase price or financial effect, so the deal's impact on shareholders is not quantified.
Acquisition of The College Advisor of New York announced July 29, 2026
Founder Dr. Dean Skarlis will lead the new division as Vice President of College Advising
The firm's existing team of coaches will continue providing college planning services
Pioneer reports more than $2 billion in assets and 23 banking offices in the Capital Region of New York
MiMedx reported second-quarter 2026 net sales of $64 million, down 35% from $99 million a year earlier, and a net loss of $15 million versus net income of $10 million. The company reiterated its full-year 2026 net sales outlook of $260 million to $290 million and announced a definitive agreement to acquire Sanara MedTech for a total enterprise value of about $350 million, which shareholders will weigh against the company's weaker results.
Q2 net sales were $64 million versus $99 million a year earlier; Wound sales fell 61% while Surgical sales rose 15%.
Q2 net loss was $15 million compared with net income of $10 million in the prior-year quarter; gross margin was 69% versus 81%.
Sanara shareholders would receive $33.00 in cash and 0.4735 MiMedx shares per share, valued at $35 per share; the deal is funded partly by a $300 million term loan from Hayfin Capital Management.
The deal is expected to close by the end of 2026, subject to Sanara shareholder approval and regulatory approvals; 2026 net sales guidance of $260 million to $290 million was reiterated.
LXP Industrial Trust reported a second-quarter 2026 net loss attributable to common shareholders of $(1.6) million, or $(0.03) per diluted share, compared with net income of $27.5 million a year earlier. The same day, it disclosed a merger agreement under which Brookfield and CPP Investments would acquire all outstanding shares for $61.20 in cash, a transaction valued at about $5.2 billion including net debt and preferred equity, and the company has suspended its common dividend.
Merger agreed July 19, 2026: all outstanding shares to be acquired for $61.20 per share in cash; expected to close by the end of Q4 2026, subject to shareholder approval and other closing conditions.
Q2 2026 net loss attributable to common shareholders of $(1.6) million, or $(0.03) per diluted share, versus net income of $27.5 million, or $0.47 per diluted share, in Q2 2025.
Adjusted Company FFO of $49.5 million, or $0.84 per diluted share, up 5.0% from $0.80 a year earlier; total gross revenues of $88.1 million versus $87.7 million.
Regular common dividend suspended effective immediately under the merger agreement; the company will no longer provide earnings guidance and will not hold an earnings call.
On July 28, 2026, Tiptree Inc. agreed to acquire Universal Shield Insurance Group for $100 million in cash, with closing expected in the first quarter of 2027 pending insurance regulatory approvals. Second-quarter net income attributable to common stockholders rose to $389.2 million, or $10.30 per diluted share, mainly from discontinued operations, while continuing operations still posted a loss. The company also declared a $0.06 per share dividend payable August 24, 2026.
Acquisition of Universal Shield Insurance Group for $100 million in cash, subject to leakage adjustments; closing expected in the first quarter of 2027
Q2 2026 net income attributable to common stockholders was $389.2 million ($10.30 diluted EPS), versus $19.0 million ($0.39) in Q2 2025, driven by $395.7 million from discontinued operations
Loss from continuing operations narrowed to $6.4 million from $10.4 million; no revenue was reported in Q2 2026 versus $92 thousand a year earlier
Book value was $24.34 per share as of June 30, 2026; $0.06 dividend has a record date of August 17, 2026 and a payment date of August 24, 2026
Westin Acquisition Corp, a Cayman Islands special purpose acquisition company, signed a business combination agreement on July 22, 2026 with First Choice Healthcare Solutions, Inc. Under the deal, Westin will redomicile to Nevada as Wellgevity 360, Inc. and First Choice will become a wholly owned subsidiary, with the company valued at an equity value of up to approximately $650 million. The transaction requires shareholder and SEC approvals and is expected to close in the fourth quarter of 2026, so shareholders will face a vote and potential dilution from new shares issued.
Business combination agreement signed July 22, 2026; Westin to redomicile to Nevada as Wellgevity 360, Inc.
Equity value of up to approximately $650 million, paid in PubCo common stock
PIPE investors may buy up to $10,000,000 of PubCo preferred stock, with no subscription agreements executed yet
Transaction expected to close in the fourth quarter of 2026, subject to shareholder and SEC approvals
AT&T completed its previously announced purchase of wireless spectrum licenses from EchoStar for approximately $23 billion on July 28, 2026. The company drew $14.5 billion across two term loans to help fund the purchase, and it reiterated its second-quarter 2026 financial outlook and capital allocation plan.
Purchase price of approximately $23 billion in cash for 600 MHz and 3.45 GHz band licenses, closed July 28, 2026
Term loan draws: $11.5 billion on a two-year facility and $3.0 billion on a 364-day facility, under a $17.5 billion Delayed Draw Term Loan Credit Agreement with Bank of America, N.A. as agent
AT&T reiterated the financial outlook and capital allocation plan from its second-quarter 2026 earnings release
EchoStar and other seller parties closed the sale of their 3.45 GHz and 600 MHz spectrum licenses to an AT&T subsidiary on July 28, 2026, receiving $20.25 billion in proceeds. Proceeds also funded a $2.4 billion FCC-mandated trust for claims tied to the sold network, and related DISH debt was repaid in full.
Seller received $20.25 billion in proceeds; an additional $2.4 billion was deposited by the buyer into the FCC Trust.
All amounts under a DISH DBS-to-DISH Network loan agreement were satisfied in full at closing.
About $3.686 billion of 11 3/4% Senior Secured Notes due 2027 was redeemed in full at closing.
DISH DBS repaid $2 billion of 7.75% Senior Notes due July 1, 2026, with accrued interest, under bankruptcy court authorization.
Leonardo DRS agreed to buy Raft LLC, a Virginia-based provider of open-architecture mission software and AI for data fusion, in an all-cash deal valued at $450 million. The company expects the deal to close in the fourth quarter of 2026 and to be accretive to Adjusted Diluted EPS in the first full year of ownership, subject to regulatory approvals.
Purchase price: $450 million all-cash, subject to customary post-closing adjustments
Expected tax benefit over 15 years with present value of approximately $50 million
Expected closing: fourth quarter of 2026; funding from cash on hand and revolving credit facility borrowings
Management will discuss the deal on the Q2 2026 earnings call on July 30, 2026
Maison Solutions and its subsidiary AZLL signed a July 22, 2026 agreement to form Maison AI Limited, a Hong Kong company that will develop AI software for grocery retail and supply chains. AZLL would hold about 90.09% of the new company in exchange for contributing the Drem and WSYQR systems valued at $2,000,000, while two investors would pay $220,000 in cash for the remaining stakes.
AZLL would hold 200 of 222 shares (about 90.09%) after closing; Hangzhou Shengxianbao Technology and Yiwu Yanghan E-Commerce Firm would each pay $110,000 for 11 shares (about 4.96%).
The Software is valued at $2,000,000 and the company and its subsidiaries keep a perpetual, non-exclusive, royalty-free internal use license.
Cash payments are due in six monthly installments starting on or about September 1, 2026.
Closing is subject to conditions, and either side may terminate if it has not closed by March 31, 2027.
Denali Therapeutics completed the sale of its Rare Pediatric Disease Priority Review Voucher to a large pharmaceutical company on July 27, 2026, receiving gross proceeds of $195.0 million at closing. The voucher was received when the FDA approved AVLAYAH (tividenofusp alfa) for Hunter syndrome in March 2026, and the sale was made under an asset purchase agreement dated June 12, 2026.
Gross proceeds of $195.0 million received from the buyer at closing on July 27, 2026
Voucher received when FDA approved AVLAYAH (tividenofusp alfa) for Hunter syndrome (MPS II) in March 2026
Sale made under asset purchase agreement dated June 12, 2026; buyer not named in the filing
Full agreement to be filed as an exhibit to a later SEC filing
Talos Energy agreed to acquire a 50% working interest in Block 29 offshore Mexico, operated by Repsol, for a contingent $30 million payment at final investment decision, a cash carry of up to $20 million on the next exploration well, and reimbursement of certain pre-closing costs. The company also amended its credit agreement to raise capacity for Mexico project financing by $50 million, non-recourse to Talos, and to allow investments in the block without the usual free cash flow test before December 31, 2027. Closing depends on Mexican regulatory approvals, and the estimated resource figures are not reserves.
Talos will hold a 50% working interest in Block 29, with Repsol as operator and sole co-participant.
Contingent $30 million payment at FID, plus a cash carry of up to $20 million on the next exploration well.
Polok and Chinwol discoveries estimated at more than 200 MMBoe of gross recoverable resource; partners expect to reach FID in 2027.
Second Amendment dated July 22, 2026 adds $50 million of non-recourse project financing capacity, effective on deal closing.
Lattice Semiconductor completed its acquisition of AMI on July 27, 2026, paying about $1 billion in cash and about 5.2 million shares and restricted stock units, subject to closing adjustments. The cash was funded from cash on hand and a $925.0 million term loan borrowed under the company's credit agreement, so the deal adds significant debt and share issuance for shareholders to weigh. The filing gives no AMI financial results; the company says it will provide them with its second quarter 2026 results on August 4, 2026.
Total consideration of about $1 billion in cash plus about 5.2 million shares and restricted stock units, subject to adjustments.
On July 27, 2026, Lattice borrowed $925.0 million under the delayed draw term loan facility to fund the cash consideration.
On July 27, 2026, Lattice issued 4,741,352 shares of common stock to the AMI sellers, with transfer restrictions releasing 25% per 90-day period.
The company will report AMI operating results with its second quarter 2026 results on August 4, 2026.
SPAC Research Alliance Corporation III (RACC) signed a business combination agreement on July 26, 2026 to acquire 100% of OHB Pediatrics Ltd., doing business as Oak Hill Bio, in exchange for newly issued RACC common stock. The combined company would be renamed Oak Hill Bio, Inc. and trade on Nasdaq as OAKH, with closing expected by year-end 2026 subject to shareholder approval and other conditions.
Base equity value of $160 million, plus a SAFE amount, divided by $10.00 per share sets the share count issued to Oak Hill Bio shareholders
Expected gross proceeds of about $175 million, including $75 million from RACC's trust account backstopped by RA Capital and a $100 million private financing
RACC shareholders may redeem Class A shares for cash from the trust account in connection with the transaction
Either party may terminate if the deal is not closed within six months of the agreement date, subject to extension provisions
Novanta completed its acquisition of Riverpoint Medical on July 23, 2026, paying the seller approximately $1.2 billion in cash, subject to customary adjustments, with a further $250.0 million milestone payment due by January 8, 2027. The company funded the deal by borrowing $616.0 million under its credit facilities and using cash on hand, bringing consolidated debt to $854.7 million as of July 22, 2026. The company expects the deal to add $0.18 to $0.25 of adjusted earnings per share in 2027, its first full year after closing.
Closed July 23, 2026, with approximately $1.2 billion paid in cash at closing
$250.0 million milestone payment remains payable to the seller on or before January 8, 2027
$616.0 million borrowed under revolving and delayed draw term loan facilities; consolidated debt $854.7 million as of July 22, 2026
Expected to contribute $0.18 to $0.25 of adjusted EPS in 2027; 2026 impact to be discussed on the second quarter earnings call
On July 23, 2026, Safety Insurance Group, Inc. entered into a merger agreement with MAPFRE U.S.A. Corp. and its subsidiary Splash Merger Sub, Inc. Under the agreement, each outstanding share of company common stock will be converted into the right to receive $105.00 in cash, and the company will become a wholly-owned subsidiary of MAPFRE U.S.A. The board unanimously recommended that stockholders adopt the agreement, and completion depends on stockholder approval and regulatory approvals, including from the Massachusetts Commissioner of Insurance.
Merger consideration of $105.00 in cash per share of common stock, without interest.
Closing requires majority stockholder approval, expiration of HSR waiting periods, and Massachusetts Commissioner of Insurance approval.
Company termination fee of $46,243,518 in specified circumstances; Parent termination fee of $111,755,169 in specified regulatory-failure circumstances.
Termination Date is July 23, 2027, subject to automatic extension to January 23, 2028 under certain regulatory circumstances.
On July 22, 2026, Matador Resources agreed to buy Paloma Permian, LLC from EnCap Investments portfolio companies for $1.275 billion in cash, subject to customary adjustments, with closing expected in early fourth quarter 2026. The company also agreed to buy undeveloped acreage from Ridge Runner Resources II, LLC, and said it will fund both deals with cash on hand and borrowings under its reserve-based lending facility, which it expects to repay over 12 to 18 months after closing.
Paloma purchase price is $1,275,000,000 in cash, with $63,750,000 placed in escrow at signing.
Paloma assets include 16,235 net undeveloped acres in Eddy and Lea Counties, New Mexico, and estimated third quarter 2026 production of about 11,100 barrels of oil equivalent per day (57% oil), per the press release.
Closing is expected early in the fourth quarter of 2026, with an effective date of June 1, 2026.
Matador said its Rae's Creek Woodford test well recorded initial rates above 2,200 barrels of oil equivalent per day (72% oil) in a 24-hour test on June 29, 2026, and that the Ridge Runner deal would bring its Woodford position to about 50,
Freenome completed its business combination with PCSC, and the filing details the post-closing arrangements. Approximately 65,440,613 shares, about 60.9% of New Freenome common stock, are subject to registration rights, and Sponsor and certain former Freenome stockholders are restricted from transferring shares for six months after closing. Shareholders should note the potential for future resales and the new equity plans, which add shares available for issuance.
Amendment No. 1, dated July 20, 2026, reduced New Freenome's board from nine to seven directors following the Closing.
Under the Investor Rights Agreement, New Freenome must file a resale registration statement within 30 calendar days after the Closing Date.
Lock-up agreements bar transfers, with certain permitted exceptions, until six months after the Closing Date.
The 2026 Equity Incentive Plan initially reserves 14,773,227 shares, and the 2026 Employee Stock Purchase Plan initially reserves 2,462,204 shares.
Neuphoria Therapeutics signed a merger agreement on July 23, 2026, under which Merger Sub will merge into Neuphoria and Neuphoria will become an indirect wholly owned subsidiary of Scancell Holdings plc. Neuphoria stockholders would receive Scancell ADSs at an exchange ratio of 37.77199 per share plus one contingent value right, and the deal is subject to shareholder approvals, financing and Nasdaq listing conditions. Neuphoria stockholders are expected to own about 11.1% of the combined company, and the filing describes the company as having no ongoing revenue and one employee.
Exchange ratio of 37.77199 Scancell ADSs per Neuphoria common share, plus one CVR per share
Pre-merger Neuphoria stockholders expected to own approximately 11.1% of the combined company
Closing conditions include Neuphoria stockholder approval and at least $75.0 million in gross PIPE proceeds; the merger must close by February 28, 2027 unless extended
Companion release says Neuphoria had $19.4 million in cash as of March 31, 2026 and a net loss of $0.5 million for the quarter ended March 31, 2026
On July 17, 2026, EVI Industries and its subsidiaries signed three asset purchase agreements to acquire substantially all assets of Sudsies and related entities, with consideration of $22.6 million, $4.0 million and $900,000. The deals open EVI's consumer garment care services division, and management expects them to be accretive to earnings for the fiscal year ending June 30, 2027. Closing is expected within 30 to 45 days, subject to conditions, and either side may terminate if closing has not occurred by September 1, 2026.
Transaction A: $22.6 million consideration, with $1.716 million held in escrow for at least 12 months
Transaction B: $4.0 million consideration, with $232,000 held in escrow for at least 12 months
Transaction C: $900,000 consideration, including $800,000 in cash and $52,000 in escrow
Closing expected within 30 to 45 days; termination right if not closed by September 1, 2026
On July 23, 2026, Axalta entered Amendment No. 2 to its merger agreement with AkzoNobel, changing governance terms for the combined company. The amendment sets annual re-election of all MergeCo directors after an initial three-year period and a two-thirds non-executive director approval threshold for specified matters during that period. The companies said the changes leave the August 5, 2026 AkzoNobel EGM and Axalta SGM on schedule, so shareholder votes are not affected by the amendment.
Annual re-election of all MergeCo directors after the initial three-year period; the press release says this was previously contemplated after five years.
Two-thirds non-executive director approval threshold during the initial three years for director appointments and dismissals, CEO, Deputy CEO and CFO changes, Chair and Vice Chair titles, and remuneration policy amendments; the press releas
AkzoNobel EGM and Axalta SGM planned for August 5, 2026 are proceeding with existing agenda items unaffected.
Canton Strategic Holdings, Inc. sold its biotech research subsidiary, Gravitas Life Sciences, LLC, to Gravitas Collective Corp., a buyer affiliated with three former directors, and the sale closed on July 17, 2026. The company received an unsecured $3.5 million promissory note plus contingent development milestone payments, and unaudited pro forma figures show smaller net losses had the sale occurred earlier.
Sold 100% of Gravitas Life Sciences, LLC, a clinical-stage biotech unit, to Gravitas Collective Corp.; the transaction closed July 17, 2026.
Consideration: unsecured promissory note of $3.5 million at 15% annual interest, paid in kind, maturing July 17, 2029, plus possible development milestone payments.
Buyer is affiliated with former directors Vincent LoPriore, Sireesh Appajosyula and Gary Stetz; an independent special committee reviewed the terms.
Unaudited pro forma net loss: $25.8 million for 2025 versus $35.9 million as reported; $45.5 million for Q1 2026 versus $47.3 million as reported.
Northrim BanCorp agreed on July 22, 2026 to acquire PBCO Financial Corporation, the holding company of Oregon-based People's Bank of Commerce, in an all-stock merger valued at approximately $167.3 million. PBCO shareholders would receive 1.160 Northrim shares for each PBCO share, and the deal is expected to close in the fourth quarter of 2026 or early in the first quarter of 2027, subject to shareholder and regulatory approvals. The filing also marks Northrim's first out-of-state expansion and would increase the combined company's assets to about $4.2 billion, with PBCO shareholders owning about 21.1% of the combined company.
Exchange ratio: 1.160 Northrim shares per PBCO share; aggregate value about $167.3 million, or $32.36 per PBCO share, based on Northrim's $27.90 close on July 21, 2026
PBCO had about $776.6 million in assets, $570.1 million in gross loans and $610.1 million in deposits as of June 30, 2026
Termination fee of $6,692,331 payable by PBCO to Northrim under specified circumstances
Expected closing in the fourth quarter of 2026 or early in the first quarter of 2027, subject to shareholder and regulatory approvals
On July 23, 2026, LightPath agreed to sell 100% of its China subsidiary, LightPath (Zhenjiang) Optical Instrumentation Co., Ltd., to Hengtu Optical Technology Co., Ltd., a company owned by Leo Zheng and certain current management team members. The cash price is $4.5 million, paid over five years, and the company said the China operation generated about $4.5 million a year of third-party revenue in fiscal 2025 and 2026 (preliminary) that will leave consolidated revenue at closing.
Purchase price of $4.5 million, payable in full no later than the fifth anniversary of closing, with at least $500,000 per year plus interest of 4% of each installment's principal.
About $4.5 million of average annual third-party revenue from the China operation (fiscal 2025 and 2026, preliminary) will no longer be consolidated after closing.
The purchaser will supply LightPath products during a five-year Exclusive Supply Term at cost plus 10%, rising 5 points per $1 million of principal paid, to a fixed cost plus 30%.
Closing is expected in the coming weeks, subject to customary closing conditions; the filing does not give profit or EPS effects.
Scilex Holding Company agreed on July 18, 2026 to sell Vivasor Holding Company shares of Vivasor preferred stock it had acquired in January 2026, for an aggregate price of $11,999,762.28. Payment is scheduled in tranches through June 30, 2027, and Vivasor may pay in cash, in shares of Datavault AI common stock, or a combination. The buyer is led by Scilex CEO Dr. Henry Ji, who is also Vivasor's CEO, a related-party arrangement shareholders may want to weigh.
Agreement dated July 18, 2026; Scilex sells 6,101,468 Series A-1 and 355,919 Series A-2 Vivasor preferred shares
Aggregate purchase price of $11,999,762.28, with $999,980.97 due July 18, 2026 and $4,999,901.10 due on or before September 30, 2026
Remaining installments of $1,999,960.07 each fall due by December 31, 2026, March 31, 2027 and June 30, 2027
Dr. Henry Ji serves as Scilex CEO, President and Chairperson and as CEO of Vivasor
On July 22, 2026, Public Storage said it had closed its acquisition of National Storage Affiliates Trust (NSA), with NSA common shares converted at 0.1400 Public Storage common share each. The company issued about 11.2 million common shares, and a joint venture holding 313 former NSA properties took on about $2.2 billion of debt. Public Storage expects the deal to be accretive to FFO per share within the first year after closing, with accretion rising to $0.35 to $0.50 per share once $110 to $130 million of run-rate synergies are realized over three to four years.
Exchange ratio: each NSA common share became 0.1400 of a Public Storage common share, plus cash for fractional shares
About 11,200,000 Public Storage common shares issued on the closing date
Joint venture of 313 properties, valued at about $3.2 billion, financed with about $2.0 billion mortgage and $237 million mezzanine loan
Expected synergies of $110 to $130 million over three to four years, with accretion of $0.35 to $0.50 per share
BioLife Solutions agreed on July 21, 2026 to be acquired by Repligen Corporation in a merger. Each BioLife share will receive $11.25 in cash and 0.1442 Repligen shares, which the press release values at $31.00 per share, a 24% premium to the 90-day VWAP through July 21, 2026. The deal is expected to close in the fourth quarter of 2026 and requires BioLife stockholder approval and other customary conditions.
Consideration per BioLife share: $11.25 in cash plus 0.1442 Repligen common shares, valued at $31.00 total in the press release
BioLife may owe Repligen a termination fee of $59,000,000 in specified circumstances
Mergers expected to close in the fourth quarter of 2026; outside date January 31, 2027, subject to extension
BioLife preliminary second-quarter 2026 revenue of $28.5 million, up 21% from $23.4 million; full results due August 6, 2026
Vita Coco completed its acquisition of Copra, Inc. on July 22, 2026, with Copra becoming a wholly-owned subsidiary. Closing consideration was $175 million, paid partly in cash and partly in Vita Coco common stock, with up to $100 million more tied to Copra's 2028 results. The filing states that the acquisition does not materially affect Vita Coco's long-term Adjusted EBITDA margin target.
Closed July 22, 2026; Copra survives as a wholly-owned subsidiary of Vita Coco.
Closing consideration of $175 million: $140,000,210.59 in cash and 467,071 shares of Vita Coco common stock.
Earnout of at least $45 million and at most $100 million, based on Copra's 2028 Gross Profit, payable in cash, stock or both at Vita Coco's discretion.
Copra expects full-year 2026 Net Sales greater than $100 million; Vita Coco reports no change to its long-term financial targets.
Domo, Inc. signed an Asset Purchase Agreement on July 22, 2026 to sell substantially all assets of its AI and Data Platform Business to Progress Software Corporation for an aggregate purchase price of approximately $400 million, subject to cash and debt adjustments. Majority stockholders signed a written consent the same day approving the deal, so no further stockholder vote is required, and the company does not intend to liquidate, instead evaluating uses of the proceeds, including acquiring assets that could use its net operating loss carryforwards.
Purchase price is approximately $400 million, subject to a cash adjustment if acquired cash is below $25 million and an adjustment for unpaid indebtedness.
Majority stockholders executed a written consent on July 22, 2026; closing requires the Hart-Scott Rodino waiting period to expire and an information statement to be filed with the SEC.
Domo would owe Progress a $13.5 million termination fee in specified circumstances, including a competing proposal or lender enforcement actions.
Domo retains its net operating loss carryforwards and adopted a Tax Benefits Preservation Plan the same day.
On July 22, 2026, Progress Software agreed to acquire substantially all assets of Domo's AI and Data Platform Business for a purchase price of about $400 million, paid with cash and its existing revolving credit facility. The same day, Progress said its fiscal third-quarter revenue and non-GAAP earnings per share are expected to be within or above the high end of its June 30, 2026 guidance. Closing requires regulatory clearance and a Domo stockholder information statement, and the deal has no financing condition.
Purchase price of about $400 million, subject to adjustments for cash acquired at closing and outstanding indebtedness
Progress expects to close within its fiscal year ending November 30, 2026, subject to the Hart-Scott-Rodino waiting period and other customary conditions
Domo's business has about 2,400 customers; Domo's trailing twelve-month revenue was about $318 million as of April 2026, per the investor presentation
Progress reiterated Q3 guidance for revenue and non-GAAP EPS within or above the high end of the June 30, 2026 range; full results are due on a September 30, 2026 call
Repligen agreed to acquire BioLife Solutions for a total enterprise value of about $1.5 billion, paid in Repligen stock and cash, with closing expected in the fourth quarter of 2026. Repligen also reported preliminary second-quarter revenue growth of about 12% as reported and 13% organic, which it said is the company's own estimate and remains subject to its quarter-end close.
BioLife holders receive $11.25 cash plus 0.1442 Repligen shares per share, valued at $31.00 per share, a 24% premium to the 90-day VWAP ended July 21, 2026
Total enterprise value of about $1.5 billion, comprising 64% Repligen common stock and 36% cash; the cash is to come from cash on hand
Expected to close in the fourth quarter of 2026; BioLife may owe Repligen a $59,000,000 termination fee in certain circumstances
Preliminary Q2 2026 revenue growth of about 12% reported and 13% organic; Repligen will report full results on July 28, 2026
Kensington Capital Acquisition Corp. VI, a special purpose acquisition company, signed a business combination agreement on July 21, 2026, with critical minerals refiner Nth Cycle, Inc. Kensington will become a Delaware corporation renamed Nth Cycle Holdings, Inc., and its shares are expected to trade on the NYSE under the symbol NTH. The deal is expected to close in the fourth quarter of 2026, subject to shareholder approvals and other conditions, and implies a pro forma enterprise value of approximately $585 million.
Business combination agreement signed July 21, 2026; closing expected in the fourth quarter of 2026, subject to Kensington shareholder and Nth Cycle stockholder approvals
Implied pro forma enterprise value of approximately $585 million, assuming no Kensington redemptions
Up to $230 million in Kensington trust proceeds, subject to redemptions, plus a common stock PIPE of up to $100 million, with $40 million committed to date
Nth Cycle holders to receive New Nth Cycle common stock based on 50,700,200 shares divided by fully diluted capital, plus up to 20,000,000 earnout shares
Apex Treasury Corp, a blank check company listed on Nasdaq as APXT, signed a business combination agreement with AI data center developer TECfusions, Inc. that values TECfusions at $4.0 billion. The deal would make TECfusions a publicly traded company, expected to trade as TECF, with closing anticipated in the fourth quarter of 2026 subject to Apex shareholder approval and other conditions.
Equity valuation of $4.0 billion; 400.0 million new shares of common stock issued to TECfusions stockholders at $10.00 per share
$35 million private placement (PIPE) from an institutional investor at the same $10.00 per share valuation
Closing requires Apex shareholder approval and at least $45.0 million in Available Closing Cash; outside termination date is March 31, 2027
Joint investor webinar scheduled for Tuesday, July 28, 2026 at 11:00am Eastern Time
Utz Brands, Inc. entered into a merger agreement on July 20, 2026, under which Merger Sub will merge into the company and Utz will become an indirect wholly owned subsidiary of Intersnack Group GmbH & Co. KG. Each Class A share will convert into the right to receive $14.25 in cash, and the company's special committee and board recommended that stockholders vote in favor. The filing text is cut off before the full closing conditions, so completion depends on terms not shown here.
Merger Consideration: $14.25 per Class A share in cash, net of applicable withholding taxes
Parent is Intersnack Group GmbH & Co. KG; Acquiror is Idaho USA, Inc.
Special committee of disinterested directors unanimously recommended the deal, and the board approved it and recommended a stockholder vote in favor
Under the agreement, quarterly cash dividends may not exceed $0.063 per share, and special dividends may not exceed $0.01 per year
FACT II Acquisition Corp. terminated its Business Combination Agreement with Precision Aerospace & Defense Group (PAD) on July 16, 2026, and announced it on July 21. CEO Adam Gishen said unforeseen circumstances affecting a key PAD subsidiary acquisition materially altered the transaction, so the parties discontinued it, even though FACT II had received multiple financing proposals that would have exceeded the $75 million minimum cash condition. The company says it will keep evaluating other business combination opportunities.
Business Combination Agreement dated November 26, 2025, amended May 17, 2026, was terminated on July 16, 2026
Minimum cash condition in the agreement was $75 million; financing proposals received would have exceeded it in aggregate
Sponsor Support Agreement and PAD Support Agreements (January 6 and January 19, 2026) terminated as a result
FACT II will continue to evaluate alternative business combinations
First Financial Bancorp agreed on July 21, 2026 to acquire Finward Bancorp, parent of Peoples Bank, in an all-stock merger valued at about $208 million, with the deal expected to close in the fourth quarter of 2026. The company also reported second-quarter net income of $76.5 million, or $0.73 per diluted share, up from $0.71 in the first quarter, and raised its quarterly dividend to $0.26. The company says the deal is about 5% accretive to earnings per share, with an estimated 0.4% dilution to tangible book value per share at closing.
Each Finward share converts into 1.35 First Financial shares; the deal is valued at about $208 million based on the July 20, 2026 closing price.
Closing requires Finward shareholder approval and regulatory approvals, including from the Federal Reserve and the Ohio Division of Financial Institutions; a $9.0 million termination fee is payable by Finward in certain circumstances.
Second-quarter net income was $76.5 million, or $0.73 per diluted share, versus $0.71 in the first quarter; adjusted EPS of $0.80 was described as a company record.
Quarterly dividend increased to $0.26, payable September 15, 2026 to holders of record on September 1, 2026.
Horace Mann agreed to acquire Employee Services, LLC (ESI) and Reserve National Insurance Company (RNIC), and to reinsure MedMutual Life Insurance Company's group life and disability business, from Medical Mutual of Ohio. The company says the businesses add nearly $200 million in annual revenue and are expected to be immediately accretive to core earnings per share, but the deal is financed with excess capital and borrowings under its revolving credit facility.
Total net purchase price is approximately $240 million, funded by excess capital and revolving credit facility borrowings.
The businesses add nearly $200 million in annual revenue, more than one million covered lives, about 7,000 employer relationships and over 1,000 agents and brokers.
ESI transaction is expected to close in the fourth quarter of 2026; RNIC and reinsurance transaction expected to close in the first quarter of 2027, subject to regulatory approvals.
Horace Mann will host a conference call on Wednesday, July 22, 2026 at 8:30 a.m. Eastern Time.
Horace Mann Educators agreed to acquire Employee Services, LLC (ESI) and Reserve National Insurance Company (RNIC), and to reinsure MedMutual Life Insurance Company's group life and disability business, all from Medical Mutual of Ohio. The total net purchase price is approximately $240 million, financed with excess capital and borrowings under Horace Mann's existing revolving credit facility. The company expects the transactions to be immediately accretive to core earnings per share and shareholder return on equity.
Total net purchase price of approximately $240 million, funded by excess capital and revolving credit facility borrowings.
Company says the businesses add nearly $200 million in annual revenue, more than one million covered lives, and about 7,000 employer relationships.
ESI transaction expected to close in Q4 2026; RNIC and group life and disability reinsurance expected to close in Q1 2027, with RNIC also subject to regulatory approvals.
Conference call on the transactions scheduled for Wednesday, July 22, 2026, at 8:30 a.m. Eastern Time.
Innovative Solutions and Support, Inc. bought all membership interests of Sparton Aydin, LLC (Aydin Displays) from Sparton Corporation under a purchase agreement dated July 21, 2026. The company said the $24.5 million price is funded by borrowings of approximately $24.5 million under its existing J.P. Morgan Chase credit facility, which adds debt for shareholders to consider.
Purchase price of $24.5 million, subject to customary working capital, indebtedness and transaction expense adjustments
Acquisition financed by borrowings of approximately $24.5 million under the existing credit facility with J.P. Morgan Chase Bank, N.A.
Aydin is expected to generate calendar 2026 revenue of approximately $16 million, according to the press release
Seller agreed to a five-year covenant not to compete in the United States and Canada following the closing
Drugs Made In America Acquisition Corp. filed Amendment No. 3 to its merger agreement with Power Analytics Global Corp, dated July 14, 2026. The amendment requires the former sponsor to forfeit at least 50% of its founder shares, sets a $0.25 to $0.35 per-right tender offer for public rights, and restates minimum cash at a $30 million target and $15 million floor. Shareholders are affected by these changes to dilution, cash at closing, and the affiliated-party structure, which the filing says includes a fairness opinion condition.
Sponsor must forfeit at least 50% of founder shares and surrender 430,000 private placement rights for no consideration.
The company agreed to launch a cash tender, exchange offer, or consent solicitation for public rights at $0.25 to $0.35 per right, before or with the proxy mailing.
Minimum cash target is $30,000,000 with a $15,000,000 floor.
A contingent Amendment No. 4 for a possible three-party combination takes effect only if conditions are met by September 30, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.